Creatd, Inc. Completes 2024 PCAOB Audit, Achieving Two Years of Audited Financials and Clearing Path Toward SEC Re-Registration and National Exchange Uplisting

Creatd, Inc. (OTC: CRTD) has completed its 2024 PCAOB audit and submitted audited financials to OTC Markets, achieving full reporting compliance. This milestone positions the company for re-registration with the SEC, reapplication for OTCQB listing, and progression towards uplisting to a national securities exchange. Financially, Creatd reported net equity exceeding $2.9 million, an $18 million improvement since 2023, and approximately $1.5 million in 2024 revenue, a figure already matched in the first half of 2025. The company attributes this recovery and strengthened balance sheet to overcoming capital constraints and a strategic diversification through synergistic acquisitions in 2024.

Analysis

Creatd, Inc. has achieved a significant operational milestone by completing its 2024 PCAOB audit and becoming fully current with its OTC Markets reporting. This regulatory compliance is a critical step in its strategy to reapply for an OTCQB listing, re-register its securities with the SEC, and pursue an uplisting to a national exchange. The company's financial turnaround is evidenced by a substantial improvement in its balance sheet, with net equity growing by $18 million since 2023 to over $2.9 million. Furthermore, Creatd is demonstrating strong top-line momentum, having already matched its entire fiscal 2024 revenue of approximately $1.5 million within the first half of 2025. This recovery is attributed to a strategic pivot executed in 2024, where the company shifted from a single-focus model to a diversified one by acquiring and integrating synergistic businesses. This M&A-driven approach was a response to a capital-constrained environment and a challenging microcap market, allowing the company to build a more resilient operational and financial foundation.

Key Decisions for Investors

• Investors should closely monitor the progress of Creatd's reapplication to the OTCQB and its subsequent re-registration with the SEC, as these regulatory milestones are the primary catalysts for a potential stock re-rating and increased liquidity.
• Evaluate upcoming financial reports to confirm the sustainability of the rapid revenue growth observed in H1 2025 and to assess the company's path toward profitability, which is essential for validating the turnaround story.
• The M&A-driven diversification is fundamental to the company's strategy; therefore, it is prudent to assess the performance and successful integration of acquired businesses in future disclosures.
• Despite the positive developments, recognize that CRTD remains a microcap stock with a history of distress, carrying inherent volatility and risks that should be carefully managed within a portfolio.